LCK and T-cell non-Hodgkin lymphoma: A transgenic mouse study showed that only transgenic mice expressing a C-terminal deleted form of TPL2 under the control of a proximal Lck promoter developed T-cell lymphoma, suggesting that the C-terminal domain of wild-type TPL2 plays an inhibitory role in its kinase activity [37].